BioMed Central advocates full and transparent reporting. Please ensure that your paper provides the information requested below where applicable. On submitting your paper you will be asked to confirm you have included this information, or give reasons for any instances where it is not made available. You will also be asked to upload this file and it should be cited in the Methods section.
Experimental design and statistics
The following information should be included in the Methods section and inserted in the table below:
Question Answer 1. The exact sample size (n) for each experimental group/condition (as a number, not a range). Include details of a power analysis if done, or any other relevant considerations that determined the choice of sample size. For n < 6, individual data values should be shown rather than summary statistics alone. 2. A description of sample collection that enables the reader to understand whether the samples represent technical or biological replicates, and an explanation of inclusion/exclusion criteria if samples or organisms were excluded from the analysis. 3. How samples/ organisms were allocated to experimental groups and processed, and full details of the randomisation procedure used (if relevant). 4. For sample assessment by human investigators, a statement on whether the investigator was blinded to group assignment and outcome assessment, and how this blinding was achieved and evaluated (if relevant).
The 72 rats were randomly allocated into six groups (12 rats, three cages per group) according to the treatment regimen (DW, 100 and 300 mg/kg Huang Bai, 20 μg/kg rhGH, 1 μg/kg E2, and 100 μg/0.4 mL triptorelin). The sample size is based on the recent experiment in our laboratory.
A total of 72 intact 21-day-old female Sprague-Dawley rats were purchased from Samtako Co. (Gyeonggi, Republic of Korea). In this experiment, a rat in the Huang Bai 300 mg/kg group showed body weight decrease after PND 40 due to intestinal obstruction (identified post-mortem). Therefore, the rat was excluded from our analyses (That exclusion mentioned in discussion).
A total of 72 intact 21-day-old female Sprague-Dawley rats were purchased from Samtako Co. (Gyeonggi, Republic of Korea). The rats divided by four body weight groups (30-40 g, 40-50 g, 50-60 g, and 60-70 g). They were randomly put in the 18 cages (4 rats/cage) by way of uniform weight distribution. The 18 cages were randomly allocated into six groups (three cages per group) according to the treatment regimen.
The longitudinal bone length between the fluorescent line formed by tetracycline and the epiphyseal end line of the growth plate was measured by two blinded investigators (SHaL and SYK) using Image J software (National Institutes of Health; MD, USA).
5. How many times each experiment shown was replicated and an indication of the extent of variation from experiment to experiment. 6. Information on the statistical methods and measures used. It should be clear whether the tests are one-sided or two-sided, whether there are adjustments for multiple comparisons, whether medians or means are being shown, whether error bars are standard deviations (SD), standard error of mean (SEM) or confidence intervals. 7. A justification for the appropriateness of statistical tests used to assess significance. Do the data meet the assumptions of the tests? Is there an estimate of variation within each group of data, and is the variance similar between groups that are being statistically compared? In addition, information essential to interpreting the data presented should be made available in the figure and table legends. If the study involves health interventions for human participants, please refer to the relevant reporting guidelines from the EQUATOR Network, and the Biosharing Portal for reporting checklists for biological and biomedical research, where applicable.
Research involving humans
If your research involved humans, please confirm you have adhered to the relevant reporting guideline from the EQUATOR Network, and included the completed checklist as an additional file with your submission:
Answer (page and line number inserted/Not applicable for my study) -I have followed the relevant reporting for my study type, and included a populated checklist with my submission -Not applicable for my study
This experiment was not replicated (not mentioned in manuscript).
Data are expressed as the mean ± standard deviation (SD) and were analyzed using the Student's t-test (GraphPad Software, Inc.; CA, USA).
P-values <0.05 were considered statistically significant.
Not applicable for my study

Resources
A description of all resources used should be included in the Methods section, with enough information to allow them to be uniquely identified. The table below should be completed with confirmation that this was done (i.e. included in the Methods section) or is not applicable. If this has not been completed, but is applicable, you should contact the journal editorial staff before proceeding.
Answer (page and line number inserted/Not applicable for my study)
•Antibodies: report source, catalogue code, characteristics, dilutions and how they were validated for the system under study.
•Cell lines: report source, whether identity has been authenticated and whether tested for mycoplasma contamination. We encourage researchers to check the NCBI database for contamination of cell lines.
•Organisms: report source, species, strain, sex, age, husbandry, inbred and strain characteristics of transgenic and mutant animals.
•Tools (software, databases and services): report standard tool name, provider and version number, if available. For antibodies, model organisms (mice, zebrafish and flies) and tools, authors are strongly encouraged to cite Research Resource Identifiers (RRIDs). To do so, please go to the Resource Identification Portal to search for your research resource and insert the reference text into your Methods section. 
Availability of data and materials
The table below should be completed with confirmation that this was done (i.e. included in the Methods section) or is not applicable.
Answer (page and line number inserted/Not applicable for my study) All datasets on which the conclusions of the paper rely must be either deposited in publicly available repositories (where available and ethically appropriate) or presented in the main paper or additional supporting files, in machine-readable format whenever possible. If authors are unable to fulfil this requirement, they should contact journal editorial staff, after checking our list of Recommended Repositories. Links to deposited datasets, or datasets in additional files, should be explicitly referenced in a section entitled "Availability of Data and Materials". Guidance on where to deposit your data can be found on the Availability of Data and Materials policy page. If computer code was used to generate results that are central to the paper's conclusions, include a statement in the "Availability of data and materials" section to indicate how the code can be accessed. Include version information and any restrictions on availability. For deposited data and published code, a full reference with an accession number, doi or other unique identifier should be included in the reference list. If reproducible materials are generated as a result of the research (for example new animal mutants), a statement on their availability should be included.
The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.
Not applicable for my study Not applicable for my study
